These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 10611374)

  • 1. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).
    Crowder KM; Gunther JM; Jones TA; Hale BD; Zhang HZ; Peterson MR; Scheller RH; Chavkin C; Bajjalieh SM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15268-73. PubMed ID: 10611374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SV2 regulates neurotransmitter release via multiple mechanisms.
    Nowack A; Yao J; Custer KL; Bajjalieh SM
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C960-7. PubMed ID: 20702688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.
    Venkatesan K; Alix P; Marquet A; Doupagne M; Niespodziany I; Rogister B; Seutin V
    J Neurosci Res; 2012 Dec; 90(12):2317-27. PubMed ID: 22847229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cotrafficking of SV2 and synaptotagmin at the synapse.
    Yao J; Nowack A; Kensel-Hammes P; Gardner RG; Bajjalieh SM
    J Neurosci; 2010 Apr; 30(16):5569-78. PubMed ID: 20410110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission.
    Tokudome K; Okumura T; Shimizu S; Mashimo T; Takizawa A; Serikawa T; Terada R; Ishihara S; Kunisawa N; Sasa M; Ohno Y
    Sci Rep; 2016 Jun; 6():27420. PubMed ID: 27265781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic vesicle protein 2 enhances release probability at quiescent synapses.
    Custer KL; Austin NS; Sullivan JM; Bajjalieh SM
    J Neurosci; 2006 Jan; 26(4):1303-13. PubMed ID: 16436618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury.
    Fronczak KM; Li Y; Henchir J; Dixon CE; Carlson SW
    Mol Neurobiol; 2021 Nov; 58(11):6006-6019. PubMed ID: 34435329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.
    Chang WP; Südhof TC
    J Neurosci; 2009 Jan; 29(4):883-97. PubMed ID: 19176798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.
    Janz R; Goda Y; Geppert M; Missler M; Südhof TC
    Neuron; 1999 Dec; 24(4):1003-16. PubMed ID: 10624962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the SV2-like protein SVOP produces no apparent deficits in laboratory mice.
    Yao J; de la Iglesia HO; Bajjalieh SM
    PLoS One; 2013; 8(7):e68215. PubMed ID: 23894296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SV2 modulates the size of the readily releasable pool of secretory vesicles.
    Xu T; Bajjalieh SM
    Nat Cell Biol; 2001 Aug; 3(8):691-8. PubMed ID: 11483953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
    Nowack A; Malarkey EB; Yao J; Bleckert A; Hill J; Bajjalieh SM
    PLoS One; 2011; 6(12):e29560. PubMed ID: 22220214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SV2A and SV2C contain a unique synaptotagmin-binding site.
    Schivell AE; Mochida S; Kensel-Hammes P; Custer KL; Bajjalieh SM
    Mol Cell Neurosci; 2005 May; 29(1):56-64. PubMed ID: 15866046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV2B regulates synaptotagmin 1 by direct interaction.
    Lazzell DR; Belizaire R; Thakur P; Sherry DM; Janz R
    J Biol Chem; 2004 Dec; 279(50):52124-31. PubMed ID: 15466855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV2 mediates entry of tetanus neurotoxin into central neurons.
    Yeh FL; Dong M; Yao J; Tepp WH; Lin G; Johnson EA; Chapman ER
    PLoS Pathog; 2010 Nov; 6(11):e1001207. PubMed ID: 21124874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development.
    Vanoye-Carlo A; Gómez-Lira G
    Brain Res; 2019 Jul; 1715():73-83. PubMed ID: 30905653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.
    Vogl C; Tanifuji S; Danis B; Daniels V; Foerch P; Wolff C; Whalley BJ; Mochida S; Stephens GJ
    Eur J Neurosci; 2015 Feb; 41(4):398-409. PubMed ID: 25484265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina.
    Wang MM; Janz R; Belizaire R; Frishman LJ; Sherry DM
    J Comp Neurol; 2003 May; 460(1):106-22. PubMed ID: 12687700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of synaptic vesicle protein 2 (SV2) isoforms.
    Bajjalieh SM; Frantz GD; Weimann JM; McConnell SK; Scheller RH
    J Neurosci; 1994 Sep; 14(9):5223-35. PubMed ID: 8083732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.